Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
1.910
-0.060 (-3.05%)
At close: Aug 28, 2026, 4:00 PM EDT
1.910
0.00 (0.02%)
After-hours: Aug 28, 2026, 5:09 PM EDT
Evotec SE Employees
Evotec SE had 4,461 employees as of June 30, 2026. The number of employees decreased by 305 or -6.40% compared to the same quarter last year.
Employees
4,461
Change
-305
Growth
-6.40%
Revenue / Employee
$183,697
Profits / Employee
-$50,464
Market Cap
690.62M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 4,461 | -305 | -6.40% |
| Mar 31, 2026 | 4,526 | -240 | -5.04% |
| Dec 31, 2025 | 4,467 | -273 | -5.76% |
| Sep 30, 2025 | 4,788 | -219 | -4.37% |
| Mar 31, 2025 | 4,766 | -289 | -5.72% |
| Dec 31, 2024 | 4,740 | -321 | -6.34% |
| Sep 30, 2024 | 5,007 | -79 | -1.55% |
| Jun 30, 2024 | 5,022 | -45 | -0.89% |
| Mar 31, 2024 | 5,055 | 103 | 2.08% |
| Dec 31, 2023 | 5,061 | 109 | 2.20% |
| Sep 30, 2023 | 5,086 | 371 | 7.87% |
| Jun 30, 2023 | 5,067 | 546 | 12.08% |
| Dec 31, 2022 | 4,952 | 754 | 17.96% |
| Sep 30, 2022 | 4,715 | 634 | 15.54% |
| Jun 30, 2022 | 4,521 | 607 | 15.51% |
| Mar 31, 2022 | 4,354 | 619 | 16.57% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 3,595 |
| Amphastar Pharmaceuticals | 1,976 |
| Canopy Growth | 1,128 |
| Pacira BioSciences | 829 |
| Kamada | 462 |
| Glass House Brands | 426 |
| Collegium Pharmaceutical | 423 |
| Evolus | 353 |
EVO News
- 16 days ago - Evotec Reports Second Quarter And First Half 2026 Results, Updates Full-Year Outlook; Stock Down - Nasdaq
- 17 days ago - Evotec SE Quarterly report: Q2 2026 - Filings
- 24 days ago - Evotec enters R&D collaboration with Odyssey Therapeutics - TheFly
- 24 days ago - Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - PRNewsWire
- 26 days ago - Niagen Bioscience selects Evotec to advance development for NB4168 - TheFly
- 26 days ago - Niagen Bioscience, Inc: Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168 - Finanz Nachrichten
- 26 days ago - Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168 - Business Wire
- 4 weeks ago - Evotec SE Slides: Company presentation - Filings